Skip to main content
main-content

Breast cancer

10-07-2018 | Breast cancer | News | Article

Acupuncture benefits unclear for aromatase inhibitor–related athralgia

Acupuncture may provide modest reductions in aromatase inhibitor-related joint pain in postmenopausal women with early-stage breast cancer, results of a multicenter study suggest.

Source:

JAMA 2018; 320: 167–176

27-06-2018 | Breast cancer | News | Article

Higher BMI linked to reduced premenopausal breast cancer risk

Increased adiposity is associated with a decreased risk for developing breast cancer before menopause, confirms a pooled analysis published in JAMA Oncology.

Source:

JAMA Oncol 2018; Advance online publication

25-06-2018 | Oncology | Main feed | News

approvalsWatch

Biosimilar trastuzumab receives EMA support

Read more on this positive opinion here

22-06-2018 | Breast cancer | News | Article

Mixed results for denosumab for the prevention of breast cancer recurrence

Two opposing sets of phase III results regarding the effect of denosumab on the recurrence of hormone receptor-positive nonmetastatic breast cancer have been presented at the ASCO Annual Meeting 2018 in Chicago, Illinois, USA.

Source:

ASCO Annual Meeting 2018; Chicago, Illinois, USA

05-06-2018 | Breast cancer | News | Article

ASCO 2018

Ovarian suppression enhances outcome in premenopausal breast cancer

Adding ovarian suppression to tamoxifen significantly improves disease-free survival over tamoxifen alone in premenopausal women with hormone receptor-positive breast cancer, the latest data from the SOFT and TEXT trials show.

Source:

N Engl J Med 2018; Advance online publication

05-06-2018 | Breast cancer | Video

ASCO 2018: TAILORx trial in breast cancer

Joseph Sparano gives an overview of his team's findings regarding a 21-gene prognostic test that could help tailor treatment for women with early breast cancer.

Funding for this video was provided in part by F. Hoffmann-La Roche Ltd, Basel, Switzerland.

image credits